Hyperalgesia	hyperalgesia	O	DISEASE	OTHERS	I
and	and	O	O	O	O
myoclonus	myoclonus	O	DISEASE	OTHERS	I
in	in	O	O	O	O
terminal	terminal	O	O	O	O
cancer	cancer	O	DISEASE	OTHERS	I
patients	patients	O	O	O	O
treated	treated	O	O	O	O
with	with	O	O	O	O
continuous	continuous	O	O	O	O
intravenous	intravenous	O	O	O	O
morphine	morphine	CHEMICALS	O	OTHERS	I
.	.	O	O	O	O

Eight	eight	O	O	O	O
cancer	cancer	O	DISEASE	OTHERS	I
patients	patients	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
terminal	terminal	O	O	O	O
stages	stages	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
disease	disease	O	O	O	O
treated	treated	O	O	O	O
with	with	O	O	O	O
high	high	O	O	O	O
doses	doses	O	O	O	O
of	of	O	O	O	O
intravenous	intravenous	O	O	O	O
morphine	morphine	CHEMICALS	O	OTHERS	I
developed	developed	O	O	O	O
hyperalgesia	hyperalgesia	O	DISEASE	OTHERS	I
.	.	O	O	O	O

All	all	O	O	O	O
cases	cases	O	O	O	O
were	were	O	O	O	O
retrospectively	retrospectively	O	O	O	O
sampled	sampled	O	O	O	O
from	from	O	O	O	O
three	three	O	O	O	O
different	different	O	O	O	O
hospitals	hospitals	O	O	O	O
in	in	O	O	O	O
Copenhagen	copenhagen	O	O	O	O
.	.	O	O	O	O

Five	five	O	O	O	O
patients	patients	O	O	O	O
developed	developed	O	O	O	O
universal	universal	O	O	O	O
hyperalgesia	hyperalgesia	O	DISEASE	OTHERS	I
and	and	O	O	O	O
hyperesthesia	hyperesthesia	O	O	OTHERS	I
which	which	O	O	O	O
in	in	O	O	O	O
2	2	O	O	O	O
cases	cases	O	O	O	O
were	were	O	O	O	O
accompanied	accompanied	O	O	O	O
by	by	O	O	O	O
myoclonus	myoclonus	O	DISEASE	OTHERS	I
.	.	O	O	O	O

In	in	O	O	O	O
3	3	O	O	O	O
patients	patients	O	O	O	O
a	a	O	O	O	O
pre-existing	pre-existing	O	O	O	O
neuralgia	neuralgia	O	O	OTHERS	I
increased	increased	O	O	O	O
to	to	O	O	O	O
excruciating	excruciating	O	O	O	O
intensity	intensity	O	O	O	O
and	and	O	O	O	O
in	in	O	O	O	O
2	2	O	O	O	O
of	of	O	O	O	O
these	these	O	O	O	O
cases	cases	O	O	O	O
myoclonus	myoclonus	O	DISEASE	OTHERS	I
occurred	occurred	O	O	O	O
simultaneously	simultaneously	O	O	O	O
.	.	O	O	O	O

Although	although	O	O	O	O
only	only	O	O	O	O
few	few	O	O	O	O
clinical	clinical	O	O	O	O
descriptions	descriptions	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
relationship	relationship	O	O	O	O
between	between	O	O	O	O
hyperalgesia/myoclonus	hyperalgesia/myoclonus	O	O	O	O
and	and	O	O	O	O
high	high	O	O	O	O
doses	doses	O	O	O	O
of	of	O	O	O	O
morphine	morphine	CHEMICALS	O	OTHERS	I
are	are	O	O	O	O
available	available	O	O	O	O
,	,	O	O	O	O
experimental	experimental	O	O	O	O
support	support	O	O	O	O
from	from	O	O	O	O
animal	animal	O	O	O	O
studies	studies	O	O	O	O
indicates	indicates	O	O	O	O
that	that	O	O	O	O
morphine	morphine	CHEMICALS	O	OTHERS	I
,	,	O	O	O	O
or	or	O	O	O	O
its	its	O	O	O	O
metabolites	metabolites	O	O	O	O
,	,	O	O	O	O
plays	plays	O	O	O	O
a	a	O	O	O	O
causative	causative	O	O	O	O
role	role	O	O	O	O
for	for	O	O	O	O
the	the	O	O	O	O
observed	observed	O	O	O	O
behavioural	behavioural	O	O	O	O
syndrome	syndrome	O	O	O	O
.	.	O	O	O	O

The	the	O	O	O	O
possible	possible	O	O	O	O
mechanisms	mechanisms	O	O	O	O
are	are	O	O	O	O
discussed	discussed	O	O	O	O
and	and	O	O	O	O
treatment	treatment	O	O	O	O
proposals	proposals	O	O	O	O
given	given	O	O	O	O
suggesting	suggesting	O	O	O	O
the	the	O	O	O	O
use	use	O	O	O	O
of	of	O	O	O	O
more	more	O	O	O	O
efficacious	efficacious	O	O	O	O
opioids	opioids	O	O	O	O
with	with	O	O	O	O
less	less	O	O	O	O
excitatory	excitatory	O	O	O	O
potency	potency	O	O	O	O
in	in	O	O	O	O
these	these	O	O	O	O
situations	situations	O	O	O	O
.	.	O	O	O	O

